Skip to main content

Peer Review reports

From: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Original Submission
26 Jul 2022 Submitted Original manuscript
22 Sep 2022 Reviewed Reviewer Report
27 Sep 2022 Reviewed Reviewer Report
16 Oct 2022 Author responded Author comments - Andreas R. Gantenbein
Resubmission - Version 2
16 Oct 2022 Submitted Manuscript version 2
20 Oct 2022 Editorially accepted
18 Nov 2022 Article published 10.1186/s10194-022-01515-8

You can find further information about peer review here.

Back to article page